http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_985c649228fb9e33b838ab492d77680d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Kaspers |
| name | Gertjan J.L. Kaspers Gertjan JL Kaspers Gertjan J.L Kaspers |
| given-name | Gertjan J.L. Gertjan JL Gertjan J.L |
| organization-name | Paediatric Oncology/Haematology, VU University Medical Centre, Amsterdam, The Netherlands Pediatric Oncology/Hematology; VU University Medical Center; Amsterdam The Netherlands Department of Pediatric Oncology/Hematology; VU University Medical Center; Amsterdam the Netherlands Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. 3Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, the Netherlands and Department of Pediatric Oncology‐Hematology VU University Medical Center Amsterdam the Netherlands Authors' Affiliations: Departments of 1Pediatric Oncology, 2Neurosurgery, 3Radiation Oncology, 4Neuro-oncology Research Group, VU University Medical Center, Amsterdam, the Netherlands; and 5Molecular Neurogenetics Unit, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts Pediatric Oncology/Hematology, VU University Medical Center Amsterdam the Netherlands 1Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; 2Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Princess Máxima Center for Pediatric Oncology; Utrecht the Netherlands; Department of Pediatrics; Division of Oncology/Hematology VU University Medical Center; Amsterdam the Netherlands From the Departments of Pediatric Hematology/Oncology and Medical Oncology, University Hospital Vrije Universiteit, Amsterdam; the Department of Pediatric Hematology/Oncology, Sophia Children’s Hospital, Erasmus University, Rotterdam, The Netherlands; the Department of Medicine, Medical College of Ohio, Toledo, OH; and the AML-Berlin-Frankfurt-Münster Study Group and the COALL Study Group, Hamburg, Germany. 1Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.; 2Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Department of Pediatric Oncology‐Hematology VU University Medical Center Amsterdam The Netherlands Emma Children’s Hospital, Amsterdam UMC, Pediatric Oncology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands VU University Medical Center; Department of Pediatrics, Division of Oncology/Hematology; PO Box 7057 Amsterdam Netherlands 1007 MB Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Paediatric Oncology, Amsterdam, the Netherlands;; Dutch Childhood Oncology Group, Utrecht, the Netherlands;; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; and Department of Pediatric Oncology / Hematology, VU University Medical Center, Amsterdam, the Netherlands VU University Medical Center, Department of Paediatrics, Division of Oncology/Haematology, Amsterdam, The Netherlands; Brain Tumor Center Amsterdam, Cancer Center Amsterdam, VU University Medical Center and Academic Medical Center, Amsterdam, The Netherlands; Prinses Máxima Center for Pediatric Oncology and University Medical Center Utrecht, Utrecht, The Netherlands Emma's Children Hospital, Amsterdam UMC Vrjie Universiteit Amsterdam The Netherlands; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands From the Departments of Pediatric Hematology/Oncology and of Medical Oncology, University Hospital Vrije Universiteit, Amsterdam; the Department of Pediatric Hematology/Oncology, Sophia Children’s Hospital, Erasmus University, Rotterdam, the Netherlands; and the AML-BFM Study Group, Germany. Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands VU University Medical Center; Department of Pediatrics, Division of Oncology/Hematology; De Boelelaan 1117 Amsterdam Netherlands 1081 HZ C. Michel Zwaan, Marry M. van den Heuvel-Eibrink, Sophia Children's Hospital/Erasmus MC, Rotterdam; C. Michel Zwaan, International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) New Agents Committee; C. Michel Zwaan, Innovative Therapies for Children With Cancer Consortium; C. Michel Zwaan, Eveline S.J.M. De Bont, Marry M. van den Heuvel-Eibrink, Gertjan J.L. Kaspers, Dutch Childhood Oncology Group, Den Haag; Eveline S.J.M. De Bont, University of Groningen, University Medical Center Groningen,... Festus Njuguna, Robert Tenge Kuremu, Peter Saula, Patel Kirtika, Gilbert Olbara, and Sandra Langat, Moi University, Eldoret, Kenya; Hugo A. Mattijn, Gertjan J.L. Kaspers, and Saskia Mostert, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and Steve Martin, Jodi Skiles, and Terry Vik, Indiana University School of Medicine, Indianapolis, IN. 3Pediatric Hematology/Oncology, VU University Medical Center, Amsterdam, the Netherlands Department of Pediatric Oncology/Hematology VU University Medical Center Amsterdam The Netherlands; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands Gertjan J.L. Kaspers, Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam; Gertjan J.L. Kaspers and Rienk Tamminga, Dutch Childhood Oncology Group, the Hague; Rienk Tamminga, Pediatric Oncology/Hematology, Beatrix Children's Hospital/University Medical Centre Groningen, Groningen, the Netherlands; Martin Zimmermann, Dirk Reinhardt, and Ursula Creutzig, Berlin-Frankfurt-Munster Acute Myeloid Leukemia (BFM-AML) Group, Medizinische Hochschule Hannover, Hannover, Germany; Brenda Gibson,... Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, The Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands VU University Medical Center; Department of Pediatrics, Division of Oncology/Hematology; PO Box 7057 Room 6 D 120 Amsterdam Netherlands 1007 MB 1Department of Pediatrics, Pediatric Hematology and Oncology, Cancer Center, Amsterdam, the Netherlands. Emma Children's Hospital Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam Amsterdam The Netherlands; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands; Dutch Childhood Oncology Group The Hague The Netherlands Princess Máxima Center for Pediatric Oncology Utrecht Netherlands; Emma Children's Hospital Amsterdam UMC Vrije Universiteit Amsterdam Pediatric Oncology Cancer Center Amsterdam Amsterdam Netherlands; Dutch Childhood Oncology Group Utrecht Netherlands Lindsey M. Hoffman and Nicholas K. Foreman, University of Colorado Denver; Lindsey M. Hoffman and Nicholas K. Foreman, Children’s Hospital Colorado, Aurora, CO; Sophie E.M. Veldhuijzen van Zanten, Esther Hulleman, Gertjan J.L. Kaspers, Esther Sanchez, and Dannis G. van Vuurden, Vrije Universiteit University Medical Center, Amsterdam; William P. Vandertop, Academy of Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Niclas Colditz, Marion Hoffmann, Brigitte Bison, Monika Warmuth... 3Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, the Netherlands; Department of Hemato‐oncology Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands; Department of Pediatric Oncology/Hematology VU University Medical Centre Amsterdam The Netherlands Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands Pediatric Oncology Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands; Neuro-oncology Research Group, Departments of Neurosurgery and Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands Department of Pediatric Oncology, VU University Medical Center, Amsterdam, The Netherlands Pediatric Oncology, VU University Medical Center Amsterdam The Netherlands |
Incoming Links
Showing number of triples: 1 to 159 of 159.